Quantum BioPharma - QNTM Net Assets per Single Share

Graphic logo of Quantum BioPharma Ltd (QNTM)

Fluctuations in the book value of a single security on the GURU.Markets chart demonstrate the current magnitude of 1.05, which correlates with strict climate control during the transportation of plant components for Quantum BioPharma Ltd (QNTM). Production relies on Canadian laboratories and outsourced CDMO plants. However, the fragmentation of small biotech assets and health products within the holding structure may lead to a decrease in the operational efficiency of the business model.

Quantum BioPharma Ltd. (QNTM): Share Book Value from 08/16/2024 to 10/27/2026
Manufactured products of Quantum BioPharma

Book value per share determines the theoretical liquidation value of an investor's stake, calculated as the difference between total assets and liabilities per common share. Analyzing the book value per common share indicator allows for an assessment of capital management efficiency at Quantum BioPharma Ltd (QNTM) during its business transformation from the cannabinoid sector into biopharmaceutical IT solutions and the restructuring of its debt obligations.

Competitors of Quantum BioPharma Ltd (QNTM)

Accounting Value per Share Haleon Group HLN|KVUE: Book Price of a Share|VRNA (Verona Pharma plc) - Net Assets per Single Share|MENS (jyongbio.com) - Accounting Value per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share ENTX|MindWalk Holdings (HYFT) - Net Assets per Single Share|Accounting Value of a Share ABVC (abvcpharma.com)|CPIX (Cumberland Pharmaceuticals Inc.) - Net Assets per Single Share|FGEN - Book Value of One Share|Telomir Pharma - Accounting Value per Share|RANI - Book Value per Share|SNYR: Book Value per Share|RLYB (Rallybio) - Book Value per Share|Net Assets per Single Share Lexaria Bioscience Corp (LEXX)|Equity per Share Pulmatrix Inc (PULM)|Accounting Value per Share Pheton Holdings Ltd|Book Price of a Share aptorumgroup.com APM|Accounting Value per Share LYRA (Lyra Therapeutics, Inc.)|Impact BioMedical, Inc. - Book Value per Share|TNFA: Net Assets per Single Share|cbdMD, Inc. (YCBD) - Accounting Value per Share|Accounting Value per Share PainReform Limited PRFX|Altamira Therapeutics Ltd. (CYTO) - Accounting Value of a Share|Book Value per Share Lipella Pharmaceuticals|Net Assets per Single Share optinose.com|PIRS (Pieris Pharmaceuticals, Inc.) - Book Value per Share|Net Assets per Share PROC (Procaps Group)|PTPI: Net Assets per Single Share|Qilian International Corp - Net Asset Value per Share|Net Assets per Single Share Acelyrin, Inc.|TFFP - Share Book Value